LUPETTI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 11.166
AS - Asia 4.793
EU - Europa 4.560
SA - Sud America 731
Continente sconosciuto - Info sul continente non disponibili 497
AF - Africa 147
OC - Oceania 11
Totale 21.905
Nazione #
US - Stati Uniti d'America 10.849
IT - Italia 1.866
SG - Singapore 1.531
CN - Cina 1.307
HK - Hong Kong 756
BR - Brasile 610
DE - Germania 556
SE - Svezia 498
VN - Vietnam 365
BG - Bulgaria 275
GB - Regno Unito 241
FR - Francia 237
CA - Canada 216
FI - Finlandia 192
TR - Turchia 167
KR - Corea 166
RU - Federazione Russa 161
UA - Ucraina 148
IN - India 122
JP - Giappone 115
NL - Olanda 80
AT - Austria 76
CH - Svizzera 61
CI - Costa d'Avorio 43
BD - Bangladesh 39
PL - Polonia 39
IQ - Iraq 38
AR - Argentina 35
BE - Belgio 33
MX - Messico 27
ES - Italia 24
EC - Ecuador 22
SA - Arabia Saudita 22
PK - Pakistan 21
ZA - Sudafrica 20
IE - Irlanda 19
ID - Indonesia 18
MA - Marocco 18
MY - Malesia 18
CO - Colombia 16
VE - Venezuela 16
UZ - Uzbekistan 15
JM - Giamaica 14
EG - Egitto 13
CR - Costa Rica 11
NG - Nigeria 11
PH - Filippine 11
CZ - Repubblica Ceca 10
SN - Senegal 10
AU - Australia 9
CL - Cile 9
IL - Israele 9
NI - Nicaragua 9
PY - Paraguay 9
GR - Grecia 8
KE - Kenya 8
PA - Panama 8
AE - Emirati Arabi Uniti 6
GT - Guatemala 6
HN - Honduras 6
IR - Iran 6
AZ - Azerbaigian 5
BB - Barbados 5
JO - Giordania 5
KH - Cambogia 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
EE - Estonia 4
EU - Europa 4
HU - Ungheria 4
KG - Kirghizistan 4
OM - Oman 4
RS - Serbia 4
TH - Thailandia 4
UY - Uruguay 4
BN - Brunei Darussalam 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KW - Kuwait 3
QA - Qatar 3
RO - Romania 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
BY - Bielorussia 2
DK - Danimarca 2
GD - Grenada 2
GE - Georgia 2
HR - Croazia 2
LT - Lituania 2
LV - Lettonia 2
NA - Namibia 2
NO - Norvegia 2
Totale 21.382
Città #
Ashburn 1.181
Singapore 874
Houston 788
Woodbridge 779
Hong Kong 739
Fairfield 718
Ann Arbor 674
San Jose 644
Santa Clara 565
Chandler 508
Dallas 412
Council Bluffs 331
Milan 318
Seattle 278
Shanghai 274
Sofia 274
Beijing 261
Wilmington 259
Serra 242
Cambridge 230
New York 220
Hefei 191
Los Angeles 184
Jacksonville 174
Boardman 169
Pisa 164
Seoul 163
Princeton 141
Munich 138
Ottawa 138
Frankfurt am Main 125
Lauterbourg 112
Lawrence 111
Medford 106
Tokyo 100
Bremen 98
Izmir 92
Nanjing 91
Des Moines 84
Rome 83
Ho Chi Minh City 79
Helsinki 76
Florence 70
London 65
Dearborn 60
Buffalo 59
Vienna 59
Hanoi 58
Dong Ket 57
São Paulo 51
Redondo Beach 50
Bern 47
Istanbul 45
San Diego 45
Abidjan 43
Lucca 42
Washington 39
Marseille 37
Nanchang 34
Jüchen 30
Warsaw 30
Phoenix 27
Chicago 26
Atlanta 24
Brussels 23
Columbus 23
Redwood City 23
Boydton 22
Pune 21
Kunming 20
Nuremberg 20
Ogden 20
San Francisco 20
The Dalles 20
Boulder 19
Montreal 19
Rio de Janeiro 19
Turku 19
Shenyang 18
Changsha 17
Da Nang 17
Toronto 17
Jiaxing 16
Turin 16
Dublin 15
Hebei 15
Hyderabad 15
Lancaster 15
Livorno 15
Naples 15
Baghdad 14
Baltimore 14
Curitiba 14
Guangzhou 14
Orem 14
Belo Horizonte 13
Brasília 13
Denver 13
Manchester 13
Zurich 13
Totale 14.800
Nome #
Identification and Pathogenic Potential of Clinical Bacillus and Paenibacillus Isolates 383
Maternal anthropometric variables and clinical factors shape neonatal microbiome 350
Evaluation of a multiplex Real-Time PCR assay for the diagnosis of human intestinal protozoa in Azienda Ospedaliero Universitaria Pisana 344
Comparative evaluation of antimicrobial activity of different types of ionic liquids 286
Diagnosis of bloodstream infections by mass spectrometry : present and future 260
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 242
Direct inoculation of positive blood cultures using the Phoenix system for antimicrobial susceptibility testing of both Gram-positive and Gram-negative bacteria 224
Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy 220
Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes 218
CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis 218
Antimicrobial Activity of a New Aloe vera Formulation for the Hygiene of the Periocular Area 216
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 214
Identification of Candida albicans karyotypes characterized by a high proteolytic activity. 213
Anti-biofilm Activity of the synthetic peptide hLF 1-11 against different Candida species in Lumen Catheters. 213
A comparison of skin storage methods for oculoplastic surgery 210
99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus 209
Molecular basis of resistance to azole antifungals. 208
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 207
Comparative evaluation of six chromogenic media for presumptive yeast identification 205
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. 200
Pushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification 199
Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice. 198
Radiopharmaceuticals: new antimicrobial agents 198
Antifungal effect of the antimicrobial peptide hLF(1-11) on invasive infections with Candida albicans. 198
Effects of Pseudomonas aeruginosa on immune functions. 194
Recent advances in the microbiological diagnosis of bloodstream infections 192
Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections 191
Analysis of the microbial content of probiotic products commercialized worldwide and survivability in conditions mimicking the human gut environment 188
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases 187
Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11 186
Saponin promotes rapid identification and antimicrobial susceptibility profiling of Gram-positive and Gram-negative bacteria in blood cultures with the Vitek 2 system 185
Detection of fungal infections using radiolabeled antifungal agents 182
Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains 182
CORT0C04210 is required for Candida orthopsilosis adhesion to human buccal cells 182
Candidacidal activities of human lactoferrin peptides derived from the N terminus 178
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert 178
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area 178
Rapid and Accurate Identification of Nontuberculous Mycobacteria Directly from Positive Primary MGIT Cultures by MALDI-TOF MS 176
From positive blood culture to microbiological diagnosis in 4 hours by MALDI-TOF mass spectrometry bacterial identification and rapid antibiogram. 176
Radiotracers for fungal infection imaging 176
A new culture-based method for rapid identification of microorganisms in polymicrobial blood cultures by MALDI-TOF 172
Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin 170
Human antimicrobial peptides’ antifungal activity against Aspergillus fumigatus 169
Identification of Bacillus species: Implication on the quality of probiotic formulations 169
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains 168
Reactivation of Graves' Orbitopathy after Rehabilitative Orbital Decompression 168
TAS2R38 polymorphisms, Helicobacter pylori infection and susceptibility to gastric cancer and premalignant gastric lesions 168
Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species 167
Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation 164
Pulmonary sporotrichosis with hyphae in a human immunodeficiency virus-infected patient. A case report. 163
Technetium-99m labeled cationic antimicrobial peptides for infection detection and treatment monitoring 163
Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin 163
The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters 163
A Rapid Procedure for Identification and Antifungal Susceptibility Testing of Yeasts From Positive Blood Cultures 163
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 163
Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections 162
Graves’ orbitopathy presenting after botulinum toxin injections 162
A comparison for skin storage methods for oculoplastic surgery 162
FlhF Is Required for Swarming Motility and Full Pathogenicity of Bacillus cereus 162
Synergistic activity between colistin and the ionic liquids 1-methyl-3 dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, or 1 dodecyl-1-methylpiperidinium bromide against Gram-negative bacteria 161
Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41 160
99mTc-Antimicrobial peptides: promising candidates for infection imaging 160
Identification of Candida albicans karyotypes characterized by a high proteolytic activity 159
Caratterizzazione genotipica di Candida albicans 159
99mTc-labelled antimicrobial peptides for detection of bacterial and Candida albicans infections 159
Graves’ orbitopathy in a patient with adrenoleukodystrophy after bone marrow transplantation 159
Molecular monitoring of Candida albicans infections in liver transplant recipients 159
Erratum to: Compositional Quality and Potential Gastrointestinal Behavior of Probiotic Products Commercialized in Italy (Frontiers in Medicine, (2018), 5, 10.3389/fmed.2018.00059) 158
Radiochemical and biological characteristics of Technetium-99m labelled fluconazole 158
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg 158
Candida parapsilosis sensu stricto Antifungal Resistance Mechanisms and Associated Epidemiology 158
Control of Candida albicans murine vaginitis by topical administration of polycarbophil-econazole complex 156
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 156
In vitro resistance and evolution of resistance to tavaborole in Trichophyton rubrum 156
MALDI-TOF MS Applications to the Detection of Antifungal Resistance: State of the Art and Future Perspectives 156
Anti-Staphylococcal Biofilm Effects of a Liposome-Based Formulation Containing Citrus Polyphenols 155
Characterization of the chemotaxis fliY and cheA genes in Bacillus cereus 155
Molecular targeted treatments for fungal infections: the role of drug combinations 155
Rapid and reliable identification of Gram-negative bacteria and Gram-positive cocci by deposition of bacteria harvested from blood cultures onto the MALDI-TOF plate. 155
Role of cpals4790 and cpals0660 in candida parapsilosis virulence: evidence from a murine model of vaginal candidiasis 154
Internal thiols and reactive oxygen species in the candidacidal activity exerted by a N-terminal peptide of human lactoferrin. 150
Comparison of different microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fluid 150
Proteolytic activity and SAP gene expression in Candida albicans strains having different karyotypes 148
Comparison of molecular typing methods for Candida albicans strain delineation. 148
Radiolabelled antimicrobial peptides for infection detection 148
Spotlight on the Compositional Quality of Probiotic Formulations Marketed Worldwide 148
Rapid identification of nontuberculous mycobacteria directly from positive primary MGIT coltures by MALDI-TOF MS 147
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species 145
Rapid identification and antibiotic susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 System 143
The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis 142
Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center 142
Imaging of infections with Candida albicans with 99mTc-labelled antimicrobial peptides and the antifungal agent fluconazole. 138
New rapid methods cannot replace the current method to diagnose bloodstream infections. 138
Sensitization of KPC and NDM Klebsiella pneumoniae To Rifampicin by the Human Lactoferrin-Derived Peptide hLF1-11 137
Letter to the Editor 137
Recent advances and ongoing challenges in the diagnosis of microbial infections by MALDI-TOF mass spectrometry 135
Technetium-99m labelled antimicrobial peptides and anti-infectives for the detection of bacterial and Candida albicans infections. 134
A new rapid method for direct antimicrobial susceptibility testing of bacteria from positive blood cultures 134
Anti-staphylococcal activity of a polyphenol-rich citrus extract: synergy with β-lactams and low proficiency to induce resistance 133
Letter to the Editor 132
Totale 17.840
Categoria #
all - tutte 64.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.126 0 0 0 97 189 154 36 75 80 66 50 379
2022/20231.826 201 193 114 221 244 207 15 136 330 14 130 21
2023/20241.476 138 163 166 106 236 264 43 35 39 65 71 150
2024/20254.621 94 183 84 216 470 436 474 253 418 546 594 853
2025/20264.778 303 584 521 333 495 407 697 228 339 477 206 188
2026/20271.432 145 406 869 12 0 0 0 0 0 0 0 0
Totale 21.905